[ Previous year]
Neurotechnology Ventures, Fall 2008
Course Numbers: 9.455 ~ 15.128 ~ 20.454 ~ HST.588 ~ MAS.883Instructors: J. Bonsen ~ E.S. Boyden ~ R.G. Ellis-Behnke
Units: H-level ~ 2-0-7 Units
Time: Tuesdays, 8-10pm (7-9pm after Nov. 3rd, when daylight savings ends); Begins Sept. 9, 2008
Place: Room 46-3189
Special note: Class sessions will be live link to University of Hong Kong
Description
Neurotechnology Ventures is a seminar and project-oriented course on the challenges of envisioning, planning, and building startups to bring neuroengineering innovations to the world. Each 2-hour class begins with a survey of a broad topic area, and continues with a live-case study of a current, specific, development or commercialization effort in that area. Explorations will cover a broad array of issues ranging from the deeply technical, to the analysis of market realities. Topics Include: Neuroimaging, Neurology/Psychiatry Diagnosis, Rehabilitation, Neurosurgery, Neuropharmacology, Brain Stimulation, Prosthetics, Sensory and Motor Augmentation, Regenerative Neuromedicine, and more.Limited Enrollment - Email neuroven@media.mit.edu two paragraphs summarizing your: (1) Professional Skills & Experience, and (2) Inventive/Entrepreneurial Aspirations, on or before first class day.
Student Project - Students will work in teams to analyze an opportunity and create a business plan executive summary to solve a major problem through neurotechnology. The project will develop throughout the term, with multiple reviews, and culminating in a final presentation. We expect that some projects may go on to become successful ventures.
Schedule
| Tues., Sept. 9 | Lecturers: Overview of class, introductions. Zack Lynch, Director of the Neurotechnology Industry Organization The Global Neurotechnology Industry 2008 Afterwards: Social event and networking. |
| Tues., Sept. 16 | Dr. Christopher deCharms, Omneuron Neurotechnology Applications: Real-Time Functional Brain Imaging. Lecturers: Opportunity and needs assessment. Lecturers: Sample 1-minute pitches by instructors. Afterwards: Social event and networking. |
| Thurs., Sept. 18 |
Lecturers: Office hours - ideas, strategy, and pitches. Front room of Muddy Charles Pub. |
| Tues., Sept. 23 |
Dr. Dan DiLorenzo, Founder, NeuroVista. Launching a new neurotherapeutic venture to treat epilepsy: A war story Students: Practice 1-minute pitches. Team building, drilling down. Afterwards: Social event and networking. |
| Tues., Sept. 30 |
Students: Practice 1-minute pitches. Refining the model. Philip Low, Founder, Neurovigil A Venture to Revolutionize Sleep Disorders with Automated EEG Analysis Afterwards: Social event and networking. |
| Tues., Oct. 7 |
Students: Practice 1-minute pitches. Neurology and psychiatry: The biggest needs and opportunities: Special Clinician Panel" (Drs. Andrew Cole, Carl Marci, Alvaro Pascual-Leone, Mark Boguski, and Steven Schachter) |
| Tues., Oct. 14 |
Kwok-Fai So, University of Hong Kong Molecular Mechanism of Neuroprotection in Glaucoma and Alzheimer's disease Using an Anti-aging Herbal Medicine, Gouqizi (Wolfberry) |
| Tues., Oct. 21 |
Ed Boyden, "Principles of Crafting New Ventures" and "Human, Physical, and Informational Resources for Crafting New Ventures." Note: the midterm has been replaced by ongoing 1-on-1 coaching targeted to each team, to help each team maximally improve its work. |
| Tues., Oct. 28 |
Paul Pyzowski and Andre Mercanzini, founders of Aleva Neurotherapeutics Flexible deep brain stimulation multiarray electrodes. |
| Tues., Nov. 4 |
Intelligent robotic prosthetics. Dean Kamen, inventor and founder of DEKA Research. |
| Tues., Nov. 11 |
No class. Veteran's day. |
| Tues., Nov. 18 |
No class. Society for Neuroscience Meeting, Washington, DC. |
| Tues., Nov. 25 |
Spinal cord injury, stem cells, and neuroregeneration. Prof. Wise Young, Rutgers (Director of the W M Keck Center for Collaborative Neuroscience), Spinal Cord Clinical Trial Network |
| Tues., Dec. 2 |
Final project presentations to the whole group. |
| Tues., Dec. 9 |
Final project presentations to the whole group. |
(C) 2007 Bonsen/Boyden/Ellis-Behnke/MIT